| Zhang, Jin | NIH | R01 | $1,663,760 | 9/7/2023 | 5 yrs | Integrating multi-omics, imaging, and longitudinal data to predict radiation response in cervical cancer |
| Zhang, Jin | NIH | R01 | $3,039,389 | 5/1/2023 | 5 yrs | HPV genomic structure in cervical cancer radiation response and recurrence detection has completed the first phase of peer review |
| Perkins, Stephanie | Be Positive Fdn | Private | $150,000 | 1/1/2023 | 2 yrs | Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients |
| Chaudhuri, Aadel /Eric Leuthardt/Hong Chen | NIH | NIH | $105,053 | 12/1/2022 | 4 yrs | Sonobiopsy for Noninvasive Genetic Evaluation of Glioblastoma Patients |
| Chaudhuri, Aadel /Angela Hirbe | Children’s Tumor Fdn | Private | $175,804 | 10/1/2022 | 2 yrs | Utilization of Cell Free DNA Liquid Biopsy for Diagnosis and Monitoring of Tumor Evolution in MPNST |
| Schwarz, Julie | NIH | R01 | $1,870,315 | 9/16/2022 | 5 yrs | Optimizing radiation therapy through the manipulation of glutamine metabolism |
| Zhang, Tiezhi | Tetraimaging, LLC | Industry | $111,273 | 9/16/2022 | 2 yrs | Development of multilayer strip ion chamber device for the measurement of proton flash-RT |
| Zhang, Tiezhi | Tetraimaging, LLC | Industry | $454,140 | 9/1/2022 | 2 yrs | Novel tetrahedron beam CT for point-of-care imaging in ear, nose and throat imaging |
| Lo, Will | RSNA | Private | $30,000 | 7/1/2022 | 1 yr | Integrin‐Targeted PET Imaging and Therapeutics To Predict and Mitigate Radiation‐Induced Pulmonary Fibrosis |
| Schwarz, Julie K/Eberlein, Timothy | NIH | U3 P30 | $220,500 | 7/1/2022 | 1 yr | Targeting IL-6 in the tumor microenvironment to improve treatment outcomes in cervical cancer |
| Hirbe, Angela, Chaudhuri, Aadel, Shern, Jack | Children’s Tumor Fdn | Private | $1.9M | 7/15/2022 | Utilization of Cell Free DNA Liquid Biopsy for Diagnosis and Monitoring of Tumor Evolution in MPNST | |
| Zhang, Jin | NIH | R21 | $257,125 | 6/13/2022 | 2 yrs | Deep Learning in Cervical Cancer Radiogenomics |
| Jones, Paul (Chaudhuri Lab) | Children’s Tumor Fdn | Private | $64,000 | 6/1/2022 | 2 yrs | Early Detection and Model Development of NF1-MPNST using Liquid Biopsy of ctDNA |
| Schwarz, Julie & Rentschler, Stacey | NIH | R01 | $787,498 | 6/1/2022 | 2 yrs | Mechanistic Basis of Cardiac Irradiation as a Therapy for Ventricular Tachycardia |
| Hao, Yao & Zhao, Tianyu | NIH/NCI | SBIR | $1.98M | 4/15/2022 | 2 yrs | Thermoacoustic Range Verification During Delivery of a Clinical Plan by a Synchrocyclotron: transition from research prototype to turnkey clinical device |
| Baumann, Brian | NAPT | Private | $50,000 | 2/1/2022 | 1 yr | Comparative effectiveness of proton vs. photon chemo-radiotherapy |
| Zoberi, Imran | Siteman Investment Program | Internal WU | $258,000 | 1/1/2022 | 2 yrs | Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and 1 Breast Carcinoma |
| Curiel, David | Medical College of WI | NIH | $300,718 | 12/1/2021 | 1 yr | Dissemination and Coordination Center for the SCGE Consortium: Enhanced in vivo editing of the endothelium via a novel adenovirus-AAV chimera vector |
| DeSelm, Carl | Emerson Collective | Private | $399,994 | 12/17/2021 | 2 yrs | Pharmacologically Modulated Chimeric Antigen Receptor (CAR) Dendritic Cells |
| Perkins, Stephanie | BJHF | Private | $67,202 | 10/1/2021 | 2 yrs | Adaptive Proton Therapy Program |
| Chaudhuri, Aadel | Tempus Labs, Inc. | Industry | $150,000 | 12/7/2021 | 1 yr | Cell-free DNA derived AR/enhancer locus alterations to predict resistance to AR-directed therapy |
| Robinson, Cliff | NIH R01 mPI | NIH | — | 12/1/2021 | 5 yrs | Comparative effectiveness of surgery vs stereotactic radiation therapy for stage 1 lung cancer |
| Sun, Baozhou | McDonnell Scholar | Internal WU | $18,000 | 10/1/2021 | 1 yr | Global Incubator Seed Grant from the McDonnell International Scholars Academy |
| Chaudhuri, Aadel | Children’s Discovery Institute | Private | $450,000 | 10/1/2021 | 3 yrs | Precise diagnosis and monitoring of MPNST via cell-free DNA liquid biopsy |
| Kapoor, Vaishali | Elsa Pardee | Private | $119,261 | 10/1/2021 | 1 yr | Anti-PDZ domain antibodies conjugated to radiosensitizers to enhance the efficacy of radiation therapy of lung cancer |
| Curiel, David | Walking Fish Therapeutics | Industry | $436,055 | 10/1/2021 | 2 yrs | Adapter-based adenovirus retargeting for B cells |
| Chaudhuri, Aadel | MIRA R35 ESI | NIH | $1.9M | Aug 2021 | 5 yrs | Liquid Biopsy |
| Zhang, Tiezhi | Tetraimaging, LLC/STTR | Industry | $68,229 | 9/21/2021 | 1 yr | Super-resolution dual-energy dental CT based on distributed x-ray source and photon counting detector |
| Chen, Hong & Rogers, Buck | NIH UG3 | NIH | $715,574 | 9/1/2021 | 3 yrs | iSonogenetics for incisionless cell-type-specific neuromodulation of non-human primate brains |
| Chen, Hong | SIP RDA – Team Science Award Category | Siteman | 2021 Cycle 1 | WUSTL Glioblastoma Team Science: An integated and collaborative approach to develop new therapies for glioblastoma | ||
| Zhang, Jin | SIP RDA | Siteman | — | 2021 Cycle 1 | 2 yrs | HPV genomic structural subtypes in oropharyngeal squamous cell carcinoma |
| Kim, Taeho | SIP RDA | Siteman | $199,921 | 2021 Cycle 1 | 2 yrs | MRI augmented X-ray imaging-guided adaptive radiotherapy for pancreatic cancer (MAX-guided ART) |
| Bergom, Carmen | NIH R01 (transfer grant) | NIH | $1,471,801 | 7/1/2021 | 3 years | Genetic Modifiers of Radiation Therapy-Induced Cardiotoxicity |
| Totelli, Brett | RSNA Medical Student Grant | Foundation | $3,000 | 2021 | 1 year | The vaginal microbiome and chemoradiation in locally advanced cervical cancer |
| Azab, Kareem | Glycomimetics, Inc. | Contract | $64,835 | 6/10/2021 | 6 months | Targeting tumor-associated endothelium, with liposomes targeted with small molecules against E-select |
| Zhang, Tiezhi | Mevion Medical Systems | Private | $128,318 | 4/20/2021 | 1 year | Fluence-aperture alternating optimization (FAAO) planning method for hyperscan adaptive aperture TRE |
| Zhang, Tiezhi | NIH R03 | NIH | $78,750 | 4/15/2021 | 8 months | Development of mmWave Technology for Safe Radiation Treatment Delivery |
| Bergom, Carmen | Komen Research | Private | $32,172 | 4/9/2021 | 1 year | Enhancing Breast Cancer Treatment Responses by Targeting Genetic Host Factors |
| Yang, Joanna | ICTS | NIH / Internal WU | $5,000 | 4/6/2021 | 1 year | Estimating real-world endocrine therapy adherence using claims data |
| Goldstein, Michael | TIPS | Internal WU | $7,500 | 4/1/2021 | until spent | The Interesting Patient Study (TIPS) program |
| Zhang, Jin | ICTS | NIH / Internal WU | $50,000 | 3/1/2021 | 1 year | Examine Cervical Cancer HPV Genotypic Radiation Response using Augmented Structural Gene Expression Differences |
| Thotala, Dinesh | Polaris Pharmaceuticals | Industry Sponsored | $422,338 | 1/7/2020 (award issued late) | 2 years | COMBINATION OF ARGININE DEPRIVATION AND RADIATION AS A POTENTIAL CANCER THERAPY |
| Markovina, Stephanie | ACS-IRG | Research Award | $30,000 | Jan 2021 | 1 year | EXPLOITING THE CANCER LYSOSOME AS A TOOL FOR RADIOSENSITIZATIO |
| Curiel, David | NIH-R01 | NIH Supplement | $422,338 | 1/7/2021 | 1 year | NOVEL VECTOR PLATFORM FOR GENE THERAPY |
| Chaudhuri, Aadel | V Foundation | V Scholar Award | $200,000 | 1/1/2021 | 2 years | LIQUID BIOPSY ANALYSIS OF TUMOR-INFILTRATING LEUKOCYTES FOR EARLY IMMUNOTHERAPY RESPONSE PREDICTION |
| Zhang, Jin | NIH K22 | NIH | $438,661 | 12/1/2020 | 3 years | HPV ALTERNATIVE SPLICING IN CERVICAL CANCER RADIATION RESPONSE |
| Kavanaugh, James | .Decimal | Industry Sponsored | $150,000 | 11/1/2020 | 9 months | CONSORTIUM MEMBER FOR IM-BECT TREATMENT PLANNING STUDY |
| Rogers, Buck | NIH / IL Inst of Tech | Subcontract with IIT through NIH R01 | $522,808 | 9/15/2020 | 4 years | DEVELOPMENT OF SUPERIOR CHELATION CHEMISTRY FOR 89ZR-IMMUNOPET IMAGING |
| DeSelm, Carl | Agilent Technologies | Early Career Professor Award | $50,000 | 9/1/2020 | 2 years | LIVE CELL IMAGING OF IMMUNE ACTIVATING CAR ANTIGEN PRESENTING CELLS |
| Perkins, Stephanie | BJHF Designated Fund | Siteman Investment Program Research Development Award Multi-PI pre-R01 | $3,659 | 10/1/2020 | 1 year | AVATAR ANESTHESIA ALTERNATIVE IN PEDIATRIC RADIOTHERAPY |
| Thorstad, Wade | University of Illinois at Urbana NIH | NIH | $25,406 | 8/1/2020 | 1 year | MULTIMODAL BIOMARKERS FOR OROPHARYNGEAL CANCER |
| Spraker, Matthew | Anonymous #9 Emerson Collective | Cancer Research Fund | $52,326 | 8/1/2020 | 1 year | LITE SABR M2: A PHASE II TRIAL OF PALLIATIVE LATTICE SBRT |
| Kapoor, Vaishali | National Institutes of Health | National Cancer Institute Transition Career Development Award K22 | $459,633 | 7/7/2020 | 3 years | ROLE OF MIDKINE IN MOLECULAR TARGETED THERAPY TO TIP1 FOR LUNG CANCER TREATMENT |
| Stanley, Jennifer | Radiological Society of North America | Foundation | $30,000 | 7/1/2020 | 1 year | EXPLOITING RADIATION INDUCED ANTI-TUMOR IMMUNITY IN ADVANCED-STAGE AND METASTATIC OVARIAN CANCER |
| Perkins, Stephanie | BJHF Designated Fund | Siteman Investment Program Research Development Award Multi-PI pre-R01 | $60,425 | 7/1/2020 | 1 year | EXAMINING COGNITIVE DECLINE IN MICE FOLLOWING A CLINICALLY MIMETIC BRAIN IRRADIATION PROTOCOL |
| Curiel, David | Siteman Cancer Center | BJF Project Award | $167,399 | 7/1/2020 | 1 year | Adenoviral Vector Production Infrastructure |
| Pachigolla, Suvidya | National Institutes of Health | TL-1 (Thomas Mazur sponsor) | $24,120 | 6/1/2020 | 1 year | MRI-Based Radiomics for Local Recurrence Prediction in Cervical Cancer |